Effect of progesterone on the vaccination and immune response against Chlamydia abortus in sheep

Vet Immunol Immunopathol. 2019 Jul:213:109887. doi: 10.1016/j.vetimm.2019.109887. Epub 2019 Jun 27.

Abstract

Chlamydia abortus produces ovine enzootic abortion (OEA). Symptoms are not observed until the organism colonises the placenta, eventually causing abortion. Infected animals become carriers and will shed the organism in the following oestruses. This process suggests that sex hormones might play an important role in the physiopathology of OEA, affecting the success of chlamydial clearance and also jeopardising the effectiveness of vaccination. However, the mechanisms through which sex hormones are involved in chlamydial pathogenicity remain unclear. The aim of this study, therefore, was to determine the effect of progesterone on the immune response against C. abortus and on the protection conferred by an experimental inactivated vaccine in sheep. Eighteen sheep were ovariectomised and divided into four groups: vaccinated and progesterone-treated (V-PG), vaccinated and non-treated (V-NT), non-vaccinated and non-treated (NV-NT) and non-vaccinated and progesterone-treated sheep (NV-PG). Animals from both PG groups were treated with commercial medroxyprogesterone acetate impregnated intravaginal sponges before and during the vaccination (V-PG) or just before challenge (NV-PG). The animals from both V groups were subcutaneously immunised with an experimental inactivated vaccine, which was seen to confer high protection in previous studies. All sheep were challenged intratracheally with C. abortus strain AB7 and were sacrificed on day 8 post-infection. Morbidity was measured as the variation in rectal temperature and samples of sera were collected for antibody and cytokine (IFN-γ and IL-10) analysis by commercial ELISA. In addition, lung and lymph node samples were collected for chlamydial detection by qPCR and for histopathological and immunohistochemical analyses. Sheep from the V-PG group showed less severe or no lesions and lower morbidity than the other groups. They also had the highest abundance of regulatory T-cells. The sheep from V-NT also manifested high antibody levels against C. abortus and less severe lesions than those observed in non-vaccinated sheep, which showed high morbidity, low antibody levels and severe lesions, especially in NV-NT. These results confirm the effectiveness of the experimental vaccine employed and suggest that progesterone could enhance the effect.

Keywords: Chlamydia abortus; Ovine enzootic abortion; Progesterone; Sheep; Vaccination.

MeSH terms

  • Abortion, Veterinary / immunology
  • Abortion, Veterinary / prevention & control
  • Animals
  • Antibodies, Bacterial / blood
  • Bacterial Vaccines / immunology
  • Bacterial Vaccines / therapeutic use*
  • Chlamydia / immunology
  • Chlamydia Infections / immunology
  • Chlamydia Infections / veterinary*
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Immunity, Humoral*
  • Progesterone / administration & dosage*
  • Sheep
  • Sheep Diseases / immunology*
  • Sheep Diseases / microbiology
  • Vaccines, Inactivated / immunology
  • Vaccines, Inactivated / therapeutic use

Substances

  • Antibodies, Bacterial
  • Bacterial Vaccines
  • Vaccines, Inactivated
  • Progesterone